Nanoform – Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act
Nanoform Finland Plc | Company Release | October 16, 2025…
Nanoform Outlicenses Nanoencorafenib and Signs Development and Commercialisation Agreement with A.forall and IMGA
Nanoform Finland Plc | Press Release | October 14, 2025…
Nanoforming Biologics & GLP-1s: From I.V. to Sub Q & Inhaled Delivery
Designing the most patient-centric and effective treatment options are key…
